CSIMarket
 


Precipio inc   (NASDAQ: PRPO)
Other Ticker:  
 
 

PRPO's Revenue Growth by Quarter and Year

Precipio Inc 's Revenue results by quarter and year

 



PRPO Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December - 5.45 4.33 2.39
3rd Quarter September - 5.21 4.52 2.22
2nd Quarter June - 4.44 3.53 2.36
1st Quarter March 4.93 3.43 2.82 2.45
FY   4.93 18.53 15.20 9.42

PRPOs Annual Revenue
Precipio Inc 's Revenue in the fiscal year 2024 $ 18.53 millions
Precipio Inc 's Revenue in the fiscal year 2023 $ 15.20 millions
Precipio Inc 's Revenue in the fiscal year 2022 $ 9.41 millions
Precipio Inc 's Revenue in the fiscal year 2021 $ 8.85 millions
Precipio Inc 's Revenue in the fiscal year 2020 $ 6.09 millions




PRPO Revenue first quarter 2025 Y/Y Growth Comment
Precipio inc achieved in the first quarter 2025, above Company average Revenue rise of 43.7% year on year, to $ 4.93 millions.

Looking into first quarter 2025 results within Laboratory Analytical Instruments industry 5 other companies have achieved higher Revenue growth. While Precipio Inc ' s Revenue jump of 43.7% ranks overall at the positon no. 1377 in the first quarter 2025.




PRPO Revenue ( Y/Y Growth %) 2025
2024 2023 2022
4th Quarter December - 25.87 % 81.17 % -2.05 %
3rd Quarter September - 15.27 % 103.6 % -1.33 %
2nd Quarter June - 25.78 % 49.58 % 0.85 %
1st Quarter March 43.7 % 21.63 % 15.1 % 34.62 %
FY   - 21.91 % 61.36 % 6.44 %

Financial Statements
Precipio Inc 's first quarter 2025 Revenue $ 4.93 millions PRPO's Income Statement
Precipio Inc 's first quarter 2024 Revenue $ 3.43 millions Quarterly PRPO's Income Statement


PRPO Revenue (Quarter on Quarter Growth %)

2025
2024 2023 2022
4th Quarter December - 4.61 % -4.2 % 7.66 %
3rd Quarter September - 17.34 % 28.05 % -5.93 %
2nd Quarter June - 29.45 % 25.18 % -3.67 %
1st Quarter March -9.56 % -20.79 % 17.99 % 0.41 %
FY (Year on Year)   - 21.91 % 61.36 % 6.44 %




Revenue first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #6
Healthcare Sector #246
Overall #1377

Revenue Y/Y Growth Statistics
High Average Low
124.96 % 16.63 % -158.16 %
(Jun 30 2019)   (Sep 30 2016)
Revenue first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #6
Healthcare Sector #246
Overall #1377
Revenue Y/Y Growth Statistics
High Average Low
124.96 % 16.63 % -158.16 %
(Jun 30 2019)   (Sep 30 2016)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Precipio Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
113.98 % 7.88 % -52.75 %
(Jun 30 2016)  


PRPO's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2025 Precipio Inc reported drop in Revenue from the fourth quarter by -9.56% to $ 4.93 millions, from $ 5.45 millions released in the previous quarter.

If you evaluate present downturn at the I. Quarter, you must assume, that commonly I. Quarter 2025 results appear to be weaker in contrast to the fourth quarter,Most analysts added.

Within Laboratory Analytical Instruments industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Precipio Inc 's Revenue growth quarter on quarter, overall rank is 2125.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #5
Healthcare Sector #288
Overall #2125
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #5
Healthcare Sector #288
Overall #2125
Revenue Q/Q Growth Statistics
High Average Low
113.98 % 7.88 % -52.75 %
(Jun 30 2016)  


PRPO's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2025 Precipio Inc realized drop in Revenue sequentially by -9.56% to $ 4.93 millions, from $ 5.45 millions achived in the previous reporting period.

But that's not big problem, as I. Quarter Revenue frequently seem to slow in this quarter.

Within Laboratory Analytical Instruments industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Precipio Inc 's Revenue growth quarter on quarter, overall rank is 2125.


Precipio Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2025)
12 Months Ending
(Dec 31 2024)
12 Months Ending
(Sep 30 2024)
12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
Cumulative Revenue 12 Months Ending $ 20.03 $ 18.53 $ 17.41 $ 16.72 $ 15.81
Y / Y Revenue Growth (TTM) 26.67 % 21.95 % 31.31 % 52.61 % 61.64 %
Year on Year Revenue Growth Overall Ranking # 133 # 148 # 236 # 580 # 1388
Seqeuential Revenue Change (TTM) 8.08 % 6.44 % 4.13 % 5.74 % 4.05 %
Seq. Revenue Growth (TTM) Overall Ranking # 1377 # 736 # 499 # 707 # 1330


Cumulative Revenue growth Comment
Precipio Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 26.67% year on year, to $ 20 millions if the fiscal year would have ended in Mar 31 2025.
Precipio Inc 's trailing twelve months Revenue growth was higher than company's average 16.63% and higher than 21.95% growth in Dec 31 2024.
But from the previous reporting period increase was beneth at 8.08 % from $18.53 millions reported in twelve months ending a quarter before.
It appears to be stagnation in progress, more evident observing the If you usual sequential Revenue rise what is better at16.63%.
The progress is even stronger from the previous reporting period showed at 8.08 % rise from $18.53 millions in the period from Dec 31 2024 to Mar 31 2024.

In the Healthcare sector 42 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 133, from total ranking in previous quarter at 148.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 6
Healthcare Sector # 43
Overall # 133

Revenue TTM Y/Y Growth Statistics
High Average Low
124.96 %
16.63 %
-158.16 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 246
S&P 500 # 1377
Cumulative Revenue growth Comment
Precipio Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 26.67% year on year, to $ 20 millions if the fiscal year would have ended in Mar 31 2025.
Precipio Inc 's trailing twelve months Revenue growth was higher than company's average 16.63% and higher than 21.95% growth in Dec 31 2024.
But from the previous reporting period rise was beneth at 8.08 % from $18.53 millions reported in twelve months ending a quarter before.
We witness drop-off developing, more evident if you pay attention to the If you usual Q/Q TTM Revenue rise which is stronger at16.63%.
The progress was even stronger sequentially exhibited at 8.08 % increase from $18.53 millions in the period from Dec 31 2024 to Mar 31 2024.

In the Healthcare sector 42 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 133, from total ranking in previous quarter at 148.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 6
Healthcare Sector # 43
Overall # 133

Revenue TTM Y/Y Growth Statistics
High Average Low
124.96 %
16.63 %
-158.16 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 246
S&P 500 # 1377




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PRPO's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for PRPO's Competitors
Revenue Growth for Precipio Inc 's Suppliers
Revenue Growth for PRPO's Customers

You may also want to know
PRPO's Annual Growth Rates PRPO's Profitability Ratios PRPO's Asset Turnover Ratio PRPO's Dividend Growth
PRPO's Roe PRPO's Valuation Ratios PRPO's Financial Strength Ratios PRPO's Dividend Payout Ratio
PRPO's Roa PRPO's Inventory Turnover Ratio PRPO's Growth Rates PRPO's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Mar 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2025
Akebia Therapeutics Inc 75.84%$ 75.840 millions
Catheter Precision Inc 74.39%$ 74.390 millions
Kiniksa Pharmaceuticals International Plc72.54%$ 72.538 millions
Seer Inc 72.00%$ 72.003 millions
Crispr Therapeutics Ag71.63%$ 71.627 millions
Therapeuticsmd Inc67.95%$ 67.949 millions
Avita Medical Inc 66.73%$ 66.733 millions
Schrodinger Inc 65.93%$ 65.926 millions
Assembly Biosciences Inc 62.82%$ 62.818 millions
Axsome Therapeutics Inc 61.95%$ 61.953 millions
Sanuwave Health Inc 61.46%$ 61.459 millions
Mirum Pharmaceuticals Inc 61.20%$ 61.199 millions
Ardelyx inc 61.04%$ 61.037 millions
Procept Biorobotics Corporation57.06%$ 57.063 millions
Biocryst Pharmaceuticals Inc 56.89%$ 56.891 millions
Blueprint Medicines Corporation55.45%$ 55.451 millions
Beigene Ltd 48.83%$ 48.828 millions
Transmedics Group Inc 48.21%$ 48.205 millions
Xeris Biopharma Holdings Inc 47.94%$ 47.938 millions
Ocugen Inc 46.06%$ 46.055 millions
Ligand Pharmaceuticals Incorporated45.42%$ 45.419 millions
Eli Lilly And Company45.17%$ 45.170 millions
Macrogenics Inc 44.90%$ 44.903 millions
Volitionrx Limited43.64%$ 43.635 millions
Precipio inc 43.62%$ 43.619 millions
Catalyst Pharmaceuticals Inc 43.56%$ 43.562 millions
Ani Pharmaceuticals Inc43.43%$ 43.434 millions
Star Equity Holdings Inc 41.74%$ 41.742 millions
Ufp Technologies Inc 41.38%$ 41.379 millions
Ss Innovations International Inc40.77%$ 40.765 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com